Year: 2025

ROCKVILLE, Md., Oct. 24, 2025 (GLOBE NEWSWIRE) — Theriva™ Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, announced today that the Company had become aware of unusual trading activity in its common stock on the NYSE American (the “NYSE”) on October 24, 2025. The Company is issuing this press release pursuant to Section 401(d) of the NYSE Company Guide. The Company has made inquiries and does not believe corrective actions are appropriate. The Company is further announcing that there has been no material development in its business and affairs not previously disclosed or, to its knowledge, any other reason to account for the unusual market action. However, on October 13, 2025,...

Reykjavík, Oct. 24, 2025 (GLOBE NEWSWIRE) — Amaroq Ltd.(“Amaroq” or the “Company”) TR-1 Notification and Block Listing Return TORONTO, ONTARIO – 24 October 2025 – Amaroq Ltd. (AIM, TSX-V, NASDAQ Iceland: AMRQ, OTCQX: AMRQF), an independent mine development corporation focused on unlocking Greenland’s mineral potential, has received a TR-1 notification from its shareholder JLE Group following recent share transactions.NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)  1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Amaroq Ltd.  1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)  Non-UK issuer X  2. Reason for the notification (please mark the appropriate...

PASCAGOULA, Miss., Oct. 24, 2025 (GLOBE NEWSWIRE) — HII’s (NYSE: HII) Ingalls Shipbuilding division successfully completed the second builder’s sea trials for guided missile destroyer Ted Stevens (DDG 128), building on the success of the initial trials conducted at the end of September. The Arleigh Burke-class (DDG 51) destroyer spent multiple days in the Gulf of America testing the ship’s main propulsion, combat systems and other critical systems in preparation for the future acceptance trials. “The Ingalls and Navy team demonstrated tremendous teamwork during this trial and are fully committed to delivering DDG 128 to the fleet,” Ingalls Shipbuilding DDG Program Manager Ben Barnett said. “As we move forward, our focus remains on ensuring that every system is thoroughly tested and fully operational as we progress toward readiness...

Clermont-Ferrand (France), October 24, 2025 (08:00 pm CEST). CARBIOS (Euronext Growth Paris: ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastics and textiles, informs its shareholders and the financial community that it has made available its Interim report for the first half of 2025.   This 2025 Interim report is available in English and can be downloaded from:The Company’s website at www.carbios.com under the “Investors / Regulated information” section, as well as on Euronext’s website: www.euronext.com  ### About CARBIOS:CARBIOS is a biotechnology company that develops and industrializes biological solutions to reinvent the lifecycle of plastics and textiles. Inspired by nature, CARBIOS designs enzyme-based biological processes to break down plastics,...

CALGARY, Alberta, Oct. 24, 2025 (GLOBE NEWSWIRE) — At the request of CIRO, Cielo Waste Solutions Corp. (TSXV: CMC; OTCQB: CWSFF) (“Cielo” or the “Company”) wishes to confirm that the Company’s management is unaware of any material change in the Company’s operations that would account for the recent increase in market activity. ABOUT CIELO Cielo Waste Solutions Corp. is a publicly traded company focused on transforming waste materials into high-value products. Cielo seeks to address global waste challenges while contributing to the circular economy and reducing carbon emissions. Cielo is fueling environmental change with a mission to be a leader in the wood by-product-to-fuels industry by using environmentally friendly, economically sustainable and market-ready technologies. Cielo is committed to helping society by providing environmental...

– First and only therapy FDA approved in both R/R acute myeloid leukemia (AML) with an NPM1 mutation and R/R acute leukemia with a KMT2A translocation – – Second approved indication for Revuforj in less than one year further solidifies Syndax’s leadership in menin inhibition – – Included in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for R/R NPM1 mutated AML – – Syndax to host conference call today at 2:30 p.m. ET – NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) — Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that the U.S. Food and Drug Administration (FDA) has approved Revuforj® (revumenib) for the treatment of relapsed or refractory (R/R) acute myeloid leukemia (AML) with a susceptible nucleophosmin 1 (NPM1) mutation in...

Honored for game-based learning innovations K12 ELA Village and K12 Coordinate Islands world for Minecraft Education RESTON, VA, Oct. 24, 2025 (GLOBE NEWSWIRE) — K12, a national leader in online learning for 25 years, has earned two Silver Medals from the International Serious Play Awards for its educational games, K12 ELA Village and K12 Coordinate Islands world for Minecraft Education. These student-centric games support interactive learning in English Language Arts and math according to grade-specific learning objectives.  Having served more than three million students nationwide, K12 helps students access high-quality education from home. K12’s award-winning curriculum integrates interactive games and learning environments that turn traditional lessons into hands-on experiences.  The K12 ELA Village immerses students in Grades...

Dallas, TX, Oct. 24, 2025 (GLOBE NEWSWIRE) — Vivakor, Inc. (“Vivakor” or the “Company”) (Nasdaq: VIVK), an integrated energy infrastructure & environmental services company, today announced that it has entered into securities purchase agreements with a single fundamental institutional investor for the purchase and sale of 10,909,090 shares of its common stock and 5,000,000 pre-funded warrants in a registered direct offering, for gross proceeds of approximately $3.5 million, before deducting commissions and offering expenses. The closing of the offering is expected to occur on or about October 27, 2025, subject to the satisfaction of customary closing conditions. D. Boral Capital LLC is acting as exclusive placement agent for the offering. The proposed offering of the common stock described above is being offered by the Company...